Julia Hirschberg

Associate (Leave of absence)
  • Stockholm
  • Languages:
    Swedish, English, French

Education

  • Uppsala University, LL.M, 2018
  • Université Panthéon-Assas, exchange semester, 2016–2017
     

Mandates

Mandate September 10, 2021

Vinge has advised Randviken Fastigheter AB (publ) in connection with its change of company object and re-listing on Nordic SME

Vinge advises Randviken Fastigheter AB (publ) (”Randviken”) in connection with its change of company…

Mandate May 07, 2021

Vinge is advising Acrinova in its rights issue

Vinge is advising Acrinova AB (publ) in connection with a rights issue which will provide Acrinova w…

Mandate March 11, 2021

Vinge has advised Azelio in connection with a directed share issue of SEK 596 million

Vinge has advised Azelio in connection with a directed share issue whereby Azelio raises approximate…

Mandate December 14, 2020

Vinge is advising Medivir in connection with its rights issue

Vinge is advising Medivir AB (publ) in connection with a rights issue which will provide Medivir wit…

Mandate October 23, 2020

Vinge advises the Swedish state in connection with the recapitalization of SAS

Vinge advises the Swedish state in connection with the recapitalization of SAS. The recapitalization…

Mandate September 28, 2020

Vinge advises GB HoldCo on its takeover bid for Gunnebo

Altor Fund V and Stena Adactum AB have, through the jointly controlled company GB HoldCo AB, announc…

Mandate September 10, 2020

Vinge has advised Azelio in connection with a directed share issue of SEK 270 million

Vinge has advised Azelio, a public Swedish company specialising in thermal energy storage with dispa…

Mandate August 13, 2020

Vinge advises Calliditas Therapeutics in connection with acquisition of controlling interest in Genkyotex SA

Vinge advises Calliditas Therapeutics, a specialty pharmaceutical company listed on Nasdaq Stockholm…

Mandate July 29, 2020

Vinge advises SBB in connection with an issue of D shares and mandatory convertibles

The board of directors of Samhällsbyggnadsbolaget i Norden has, on the basis of an authorization gra…

Mandate June 10, 2020

Vinge advises Calliditas

Vinge advises Calliditas Therapeutics in connection with its capital raising and listing on The Nasd…

Mandate June 04, 2020

Vinge advises Nanoform in connection with its capital raising and listing on Nasdaq First North Premier Growth markets Finland and Sweden

Vinge has advised Nanoform Finland Plc (“Nanoform”) in connection with its capital raising and listi…

Mandate December 30, 2019

Vinge has advised Azelio in connection with its rights issue

Vinge has advised Azelio AB (publ) on a fully subscribed rights issue, which will provide Azelio wit…

Mandate February 08, 2019

Vinge advises KKR on its significant investment in Söderberg & Partners

Vinge has advised the global investment firm KKR in connection with KKR entering into an agreement w…

Mandate January 30, 2019

Vinge advised Strax on an automatic redemption procedure

Vinge has advised Strax AB in connection with an automatic redemption procedure according to which e…

Mandate December 10, 2018

Vinge advises Xspray Pharma in connection with a directed share issue

The board of directors of Xspray Pharma AB (publ) has resolved on a directed new issue of shares, wh…